Skip to content
-
H.R. 1613 – Drug Price Transparency in Medicaid Act
Mar 17, 2023
Congress Takes Action to Address Anticompetitive PBM Practices in the Medicaid Program WASHINGTON, DC – On... read more
-
NASP Supports Clarification from HHS on Pandemic-Related Services at Pharmacies
Jun 08, 2022
In light of the ongoing Covid-19 response, the National Association of Specialty Pharmacy (NASP) has joined... read more
-
FTC Advances Study into PBM Practices and Impact on Specialty Pharmacies
Jun 07, 2022
WASHINGTON, DC – The National Association of Specialty Pharmacy (NASP) applauds the decision by the Federal Trade... read more
-
NASP Provides FTC Comments on PBM Business Practices and Impact on Pharmacies and Consumers
May 26, 2022
On May 25, 2022, the National Association of Specialty Pharmacy (NASP) provided comments in response to... read more
-
NASP Thanks Biden Administration for Reducing Out-of-Pocket Drug Costs for Seniors and Taking Initial Steps to Address Pharmacy DIR Fees
May 02, 2022
Urges Congress to Work with the Administration to Protect Pharmacies as CMS Delays Implementation of The... read more
-
U.S. Senators Urge OMB to Lower Prescription Drug Costs for Seniors
Apr 15, 2022
Letter Asks Office of Management and Budget (OMB) to Act Swiftly to Review CMS’ Pharmacy DIR... read more
-
Legislation to Ensure Continued Access to Critical Pharmacy Services
Mar 29, 2022
Dear Congressmen Kind and McKinley, On behalf of America’s pharmacists and pharmacies, we write to thank... read more
-
NASP Encouraged by Biden Administration’s Effort to Reduce Out-of-Pocket Drug Costs for Seniors, Asks That More Be Done to Protect the Pharmacies that Support Them
Mar 08, 2022
NASP asks the Administration to strengthen and finalize proposed rule to address egregious growth of pharmacy... read more
-
NASP’s Federal Trade Commission (FTC) Comments
Feb 17, 2022
On February 17, 2022, Sheila Arquette, President & CEO of the National Association of Specialty Pharmacy... read more
-
Pharmacy Groups Support Confirmation of Dr. Robert Califf as Commissioner of the Food and Drug Administration
Feb 14, 2022
“On behalf of pharmacists across the country who are on the frontlines during the pandemic, relying... read more